-
The total number of retail stores has exceeded 10,000!
Time of Update: 2022-04-22
At the same time, Sinopharm's medical device business network covers 335 prefecture-level cities and above, and the scale of direct sales to medical terminals exceeds 100 billion yuan, and its market share continues to rank among the forefront of the medical device circulation industry .
-
Antigen testing is temporarily included in medical insurance, capped at 15 yuan, and centralized collection is coming
Time of Update: 2022-04-22
In addition, the provincial medical insurance departments should adjust and optimize the medical security policies and measures for epidemic prevention and control in a timely manner, temporarily incorporate the novel coronavirus antigen detection reagents and corresponding detection items into the catalogue of basic medical insurance medical service items in their provinces according to procedures, and continue to standardize and optimize public medical institutions.
-
The centralized procurement of dental implants is on the verge of triggering, and many provinces have begun to fill in the procurement data
Time of Update: 2022-04-22
In addition to Ningbo, Zhejiang, Sichuan, Ningxia, Shanxi, Jiangsu and other places have also successively carried out the filling and reporting of historical procurement data of dental medical consumables.
-
The cross-provincial centralized procurement of tens of billions of decoction pieces is launched, or it may face two major challenges!
Time of Update: 2022-04-22
In 2020, the demand for this variety of decoction pieces by domestic urban medical institutions is more than 860 tons, of which more than 340 tons of raw materials come from 5 aconite decoction pieces factories in the Jiangyoudao production area in Sichuan, and the rest are from Yunnan, Shaanxi and other places, the price is from 45 yuan.
-
Where should the "water sellers" of the pharmaceutical industry transform and upgrade?
Time of Update: 2022-04-22
In the process of transformation and upgrading, CRO companies should keep their own positioning in mind, build a corporate moat through innovative R&D and talent barriers, do a good job in corporate management, maintain a differentiated competitive advantage, and be an accelerator for new drug R&D in the pharmaceutical industry .
-
Antigen testing can be paid by medical insurance account, or reimbursement policies such as "long-term prescription" and Internet diagnosis and treatment will be implemented!
Time of Update: 2022-04-22
The notice on the adjustment of new crown treatment drugs included in the scope of medical insurance payment pointed out that for the newly added drugs in the "Diagnosis and Treatment Plan (Trial Version 9)", each provincial medical security department shall refer to the "National Medical Security Administration and Ministry of Finance on Doing a Good Job in Pneumonia Infected by Novel Coronavirus" According to the relevant requirements of the “Notice of Epidemic Medical Insurance” (Guojianbaodian [2020] No.
-
Cinda/Lilly PD-1 was finally rejected, please keep the "going to sea" tips
Time of Update: 2022-04-22
In view of the short development time of cell gene therapy, most of the companies are start-ups, and their R&D and production are difficult, high cost and long cycle, and they are very dependent on CGT CDMO .
-
News from the Medical Insurance Bureau: The solution to the hospital's arrears is coming
Time of Update: 2022-04-22
It is understood that in August last year, the Shandong Provincial Medical Insurance Bureau and other four departments jointly issued the "Notice on Printing and Distributing the Implementation Plan for the Direct Settlement of Medical Insurance Funds and Pharmaceutical Enterprises for the Payment of Medical Insurance Designated Public Medical Institutions for Drugs and Medical Consumables", proposing to establish a unified settlement for medical equipment in the province.
-
Children need to use children's medicines, the 100 billion market is waiting to explode
Time of Update: 2022-04-22
The 2018 edition of the Essential Medicines List focuses on revisions to the categories, varieties, dosage forms and specifications of children's medicines, and adds 22 new types of medicines for children that are urgently needed in clinical practice, including 3 pediatric chemicals and 13 proprietary Chinese medicines .
-
Linked lowest price!
Time of Update: 2022-04-22
On March 23, Chongqing, Inner Mongolia, Hubei, Sichuan, Yunnan, and Tibet provinces (autonomous regions and municipalities) issued the "Implementation Plan for the Continued Procurement of Drugs with the Expiration of the First and Third Batches of Centralized Procurement Agreements organized by the State (Draft for Comment)" , for public comment .
-
The State Food and Drug Administration adjusts some contents of the "Medical Device Classification Catalog"
Time of Update: 2022-04-21
, liquid dressings and paste dressing products used for the care of superficial wounds such as small wounds, abrasions, incisions and the surrounding skin, from the date of this announcement, can be implemented in accordance with the "Administrative Measures for Registration and Filing of Medical Devices" (Order No.
-
The new version of the nucleic acid testing guidelines is announced. What are the highlights?
Time of Update: 2022-04-21
On March 22, the National Health and Health Commission announced the "Regional Implementation Guidelines for Novel Coronavirus Nucleic Acid Testing Organizations (Third Edition)", which revised the "full staff" in the second version of the guidelines to "regional", and the size of the region depends on the needs of epidemic prevention and control.
-
Chinese pharmaceutical company fluocinolone API first obtained the European Pharmacopoeia applicability certification
Time of Update: 2022-04-21
The CEP certificate for fluocinolone APIs for the first time by a Chinese company has opened the access channel for this product in the European market and other regulated markets that recognize the CEP certificate .
-
2022 Jinan International Senior Care Industry Expo will be held in Shandong on May 20
Time of Update: 2022-04-21
In response to the needs of market and industrial development, the 2022 Jinan International Elderly Care Service Industry Expo will be held at the Jinan International Convention and Exhibition Center from May 20 to 22, 2022.
-
Over 2 billion cardiovascular major varieties Yiling is about to win
Time of Update: 2022-04-21
com's new database Figure 2: Felodipine's sales (unit: 100 million yuan) Source: Minet.
Figure 3: Felodipine products that have been reviewed Source: Minet's new version of the database In recent years, under the impact of domestic generic drugs, AstraZeneca's market share has declined rapidly, from 82.
-
The chain rate is 57.1%!
Time of Update: 2022-04-21
In the first three quarters of 2021, the number of pharmacies in the country continued to grow, reaching 587,000, an increase of nearly 34,000 from 553,000 in 2020; the chain rate increased from 56.
-
"Correct teeth for free!" Braces experience officer, set a set of routines!
Time of Update: 2022-04-21
"The free trial service is just to let everyone experience the feeling of invisible braces, and it has no effect of correction.
Zhongxin Finance found that if consumers pay on the day of a salon or try-on event, although not free, they can usually enjoy so-called "discounted prices" .
-
With continuous plant expansion, how will the price of Huang Jing run after new production this year?
Time of Update: 2022-04-21
Huangjing, a medicinal and food homologous variety, has seen a surge in demand in recent years, and the market is also running at a high level .
Since then, the Huangjing market has been running at a high level, and the price will continue to rise slightly in 2021.
-
Rongchang's listing of "blood supplement" and Cinda's "blood transfusion" by Lilly, can the losses be reversed?
Time of Update: 2022-04-19
The two drugs, ramucirumab and sepretinib, are about to be launched, whether they can bring new business to Innovent Bio in the difficulties of consecutive years of losses.
PD-1 revenue growth slows down, and Innovent has accumulated losses of more than 12 billion yuan in consecutive years.
-
The third batch of "eight provinces and two districts" has an average drop of 54.76% and a maximum drop of 98.02%
Time of Update: 2022-04-19
Recently, the results of the third batch of drug centralized procurement of the "eight provinces and two districts" inter-provincial alliance led by Inner Mongolia have been released, involving 18 procurement varieties, involving cardiovascular and cerebrovascular diseases, respiratory diseases, and antibiotics with large clinical doses.
